Pluto Bioinformatics

GSE135997 (human): Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcR Expression

Bulk RNA sequencing

Purpose: To understand the molecular mechanisms underlying the CTX synergization with antibody therapies in resistant niche-specific organs and BM-resident tumors SOURCE: Guangan Hu (gahu@mit.edu) - Chen MIT